You are here: Industry Insights > Biologics

News List

Evolving World of Pharma: Hot Topics in Pharma for September Sarah Harding
September 11, 2018
Known for its innovation and fast-paced developments, the pharmaceutical industry’s hot topics are constantly evolving.
MilliporeSigma, InnoCore team up on extended-release platform for large biologics fiercebiotech
July 31, 2018
Merck KGaA’s U.S. life science arm, MilliporeSigma, will collaborate with InnoCore Pharmaceuticals to offer a drug delivery platform for sustained-release formulations for “virtually any class” of injectable biologic drug, using biodegradable polymers.
Quality assessment of biologics: higher order structure analysis using NMR europeanpharmaceuticalreview
July 30, 2018
The webinar will describe how 2D NMR can offer protein biochemists unprecedented analytical precision. By assigning just one spectrum.....
Boehringer to invest €230m in biologics R&D pharmaceutical-technology
June 28, 2018
Boehringer Ingelheim has revealed plans to invest €230m into a new Biologicals Development Center (BDC) set to be constructed at its Research and Development (R&D) site located in Biberach, Germany.
WuXi Biologics Expands Operations contractpharma
May 22, 2018
WuXi Biologics revealed plans to build an integrated biologics development, clinical and commercial manufacturing center in the city of Shijiazhuang, capital of Hebei province in northern China.
Thermo Fisher Invests $50M to Grow Biologics Footprint contractpharma
April 24, 2018
Thermo Fisher Scientific is investing $50 million in its St. Louis, MO site, one of the company's Centers of Excellence for biologic commercial manufacturing.
Eagle Pharma receives New Patent for Biologics biospectrumasia
April 02, 2018
The patent is directed to a technology that allows for the formulation of antibodies at high concentration
Samsung Biologics reinforces biologic manufacturing and development partnership with MSD pharmafile
October 31, 2017
Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the US and Canada, with the signing of a memorandum of understanding
Samsung BioLogics granted FDA approval for its first monoclonal antibody Drug Substance pharmaasia
October 24, 2017
The Samsung Biologics plant is the largest single plant in the world, and this licensing allows it to manufacture Biologics Drug Substances commercially.
AbbVie obtains licence for Turnstone Biologics’ oncolytic viral immunotherapies pharmaceufical-technology
October 13, 2017
Under the deal, AbbVie has obtained an exclusive option to licence up to three of Turnstone's latest oncolytic viral immunotherapies.

Previous page 1 2 3 4 5 6 7 8 9 Next page